CYPROHEPTADINE HYDROCHLORIDE
NDC 70752-232, CYPROHEPTADINE HYDROCHLORIDE, tablet, from Quagen Pharmaceuticals, LLC.
- Product NDC
- 70752-232
- Status
- Listed
- Labeler
- Quagen Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212491
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70752-232 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYPROHEPTADINE HYDROCHLORIDE2 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70752-232-03 | 70752023203 | 30 TABLET in 1 BOTTLE (70752-232-03) |
| 70752-232-05 | 70752023205 | 60 TABLET in 1 BOTTLE (70752-232-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/e6d91eae-db29-4e62-89da-1ad764de7ae1
Use it
Look up 70752-232 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70752-232 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70752-232. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.